Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

ThromboSol to be studied in chemotherapy recipients at M.D. Anderson

Aug. 2, 1999

U.S. patent provides protection for Cyclacel's Penetratin drug delivery technology

Aug. 2, 1999

Nexell and Baxter complete transfer agreements

July 30, 1999

Elan and Merck establish second technology transfer and license agreement

July 28, 1999

Phase I trial results reported for MSI pulmonary delivery of morphine

July 27, 1999

Kurtoxin-1 available for licensing from NIH

July 26, 1999

Cerep and Bristol-Myers Squibb announce collaborative agreements

July 22, 1999

Archaeosomes with or without coenzyme Q10: biodistribution in mice after i.v., i.p. and p.o. dosing

July 21, 1999

Novalon and Ares-Serono enter research collaboration

July 21, 1999

ProNeura completes proof-of-concept studies for sustained drug delivery system

July 20, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 13, 2026.
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...